HONG KONG – Newly capitalized, thanks to an IPO of its contract drug manufacturing arm that surged on its first day of trading, South Korea's Samsung Group is now looking to take a larger slice of the global biotechnology market pie.
HONG KONG – Biotech companies worldwide are gearing up to expand into the China market even as the CFDA toughens up its health care market through a series of reforms.
HONG KONG – Biotech companies worldwide are gearing up to expand into the China market even as the CFDA toughens up its health care market through a series of reforms.
HONG KONG – Newly capitalized, thanks to an IPO of its contract drug manufacturing arm that surged on its first day of trading, South Korea's Samsung Group is now looking to take a larger slice of the global biotechnology market pie.
HONG KONG – With an eye firmly set on the double-digit growth of the pharmaceutical market in Vietnam and the rest of Asia-Pacific, French drugmaker Sanofi SA recently signed a strategic cooperation agreement with Vietnam's state-run giant Vinapharm Corp.
HONG KONG – With an eye firmly set on the double-digit growth of the pharmaceutical market in Vietnam and the rest of Asia-Pacific, French drugmaker Sanofi SA recently signed a strategic cooperation agreement with Vietnam's state-run giant Vinapharm Corp.
